Efficacy of risankizumab after intra-class switching between anti IL-23 antagonists: a multi-center, retrospective, real-life observation

Affiliations

• ¹ Department of Dermatology, University of Pisa, Pisa, Italy.
• ² Section of Dermatology, Department of Medical, Surgical and Neurological Science, University of Siena, Siena, Italy.
• ³ Unit of Dermatology, San Donato Hospital, Arezzo, Italy.
• ⁴ Section of Dermatology, Department of Health Sciences, University of Florence, Florence, Italy.
• ⁵ Unit of Dermatology, Versilia Hospital, Lido di Camaiore, Lucca, Italy.
• ⁶ Department of Dermatology, San Jacopo Hospital, Pistoia, Italy.
• ⁷ Unit of Dermatology, Hospital of Campo di Marte, Lucca, Italy.
• ⁸ Unit of Dermatology, San Giuseppe Hospital, Empoli, Florence, Italy.
• ⁹ Section of Dermatology, Department of Medical, Surgical and Neurological Science, University of Siena, Siena, Italy - emanuele.trovato@unisi.it.